logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11690845 B1

PDFFull Text
Date of Patent:
Jul. 04, 2023

Filed:

Aug. 27, 2020

Methods of administering elagolix

Applicant:

Abbvie Inc., North Chicago, IL (US);

Inventors:

Farah N. Ali, Wilmette, IL (US);

Nael M. Mostafa, Libertyville, IL (US);

Ahmed Nader, Libertyville, IL (US);

Mohamad Shebley, Gurnee, IL (US);

Assignee:

AbbVie Inc., North Chicago, IL (US);

Attorney:

Neal, Gerber & Eisenberg LLP

Primary Examiner:

San Ming R Hui

Int. Cl.
CPC ...
A61K 31/513 (2006.01); A61K 31/137 (2006.01); A61K 9/00 (2006.01); A61K 31/57 (2006.01); A61K 31/565 (2006.01); A61K 31/4439 (2006.01);
U.S. Cl.
CPC ...
A61K 31/513 (2013.01); A61K 9/0053 (2013.01); A61K 31/137 (2013.01); A61K 31/4439 (2013.01); A61K 31/565 (2013.01); A61K 31/57 (2013.01);
Abstract

The present disclosure relates to the use of GnRH receptor antagonists for the treatment of endometriosis, uterine fibroids, polycystic ovary syndrome (PCOS), or adenomyosis. In particular, the present disclosure describes methods for treating such gynecological disorders, where the methods involve administration of elagolix and may further involve co-administration of a CYP2B6 substrate (e.g., bupropion) or a CYP2C19 substrate (e.g., omeprazole).

Find Patent Forward Citations

Ali, Farah. (2023). Methods of administering elagolix (U.S. Patent No. 11690845). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11690845

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…